AzTrials
AzTrials

Failed Back Surgery SyndromeNCT07050290

Restoring Segmental Lumbar Lordosis After Failed Previous Fusion at the Same Level

A study testing Restoring segmental lordosis at the lumbar spine in people with Failed Back Surgery Syndrome and Degeneration Lumbar Spine, run by N.N. Priorov National Medical Research Center of Traumatology and Orthopedics at 1 site in Russia.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The restoration of lumbar lordosis is mandatory during lumbar fusion surgery for degenerative disc disease, since not restoring lumbar lordosis adequately may adversely affect surgical outcomes and the patient's quality of life in the follow-up. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Restoring segmental lordosis at the lumbar spine
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteRussia
Study dates
25 Jun 2025to 1 Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 1. Over 18 years' old;
  • 2. Lumbar back pain with / without radicular leg pain (with / without neurological deficit) with / without neurogenic claudication, symptoms persisting for at least 3 months prior to surgery;
  • 3. 1) Failed back lumbar fusion surgery at the same level or on an adjacent segment or 2) Symptomatic discopathy with loss of segmental lordosis at one of the levels L3-L4, L4-L5 or L5-S1, confirmed by MRI и Rg, with/without degenerative stenosis/spondylolisthesis
  • 4. Need for a planned surgical procedure with a major extent of segmental lordosis restoration (more than 10°);
  • 5. Given written informed consent;
  • 6. Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements

Who cannot join

  • 1. Interbody implants previously placed via non-posterior approach at the level of surgery (which cannot be removed through the posterior approach);
  • 2. Complete interbody fusion after previous surgery at the level of surgery;
  • 3. HU values of lumbar body vertebrae less than 120 HU;
  • 4. Any contraindication or inability to undergo baseline and/or follow up MRI, CT or X-ray as required per protocol;
  • 5. Back or non-radicular pain of unknown etiology;
  • 6. History or presence of any other major neurological disease or condition that may interfere with the study assessments;
  • 7. Previous enrollment in this study, current enrollment or plans to be enrolled in another study (in parallel to this study).

Trial locations and contacts

1 site in 1 country.

Russia1 site
  • Priorov National Medical Research Center of Traumatology and Orthopedics

    Moscow, 127299

Other trials in Russia

About this study

Official title: Restoring Segmental Lordosis Via One Previous Posterior Approach After Failed Fusion at the Same Level for Degenerative Lumbar Disease

The restoration of lumbar lordosis is mandatory during lumbar fusion surgery for degenerative disc disease, since not restoring lumbar lordosis adequately may adversely affect surgical outcomes and the patient's quality of life in the follow-up. Revision surgery to restore segmental lordosis at the level of previous spinal fusion is extremely difficult to do and its performance is usually inferior to that of primary surgery. Need to provide a surgical technique to restore segmental lordosis via a posterior approach, which is especially important after failed previous fusion at the same lumbar level.

Being tested
Restoring segmental lordosis at the lumbar spine
Keywords
Lumbar fusion, segmental lordosis, revision spinal surgery, posterior approach
Medical subject headings
Failed Back Surgery Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Restoring segmental lordosis at the lumbar spineProcedure or surgery

    All patients will undergo restoring segmental lordosis via one previous posterior approach after failed fusion at the same level.

Study groups in NCT07050290
Study groupRoleWhat they receive
CohortOtherAll patients will undergo restoring segmental lordosis via one previous posterior approach after failed fusion at the same level.
Receives: Procedure: Restoring segmental lordosis at the lumbar spine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline in lumbar balance parameters

    To observe the change from baseline in segmental lordosis at operated level by CT, in degrees

    Measured: 2 weeks postoperatively (or at day of hospital discharge)

Secondary outcomes (9)
  1. Change from baseline in Numeric Pain Rating Scale

    To observe the change of Numeric Pain Rating Scale as compared to baseline through follow-up terms (0 - no pain, 10 - unbearable pain)

    Measured: 2 weeks (or at day of hospital discharge), 3 months, 12 months postoperatively

  2. Change from baseline in Oswestry Disability Index

    To observe the change of Oswestry Disability Index as compared to baseline through follow-up terms (min - 0 - the best result, patient is active; max - 50 - the worst result, patient is not physically active)

    Measured: 2 weeks (or at day of hospital discharge), 3 months, 12 and 12 months postoperatively

  3. Change from baseline in The Health Transition Item from SF-36

    To observe the The Health Transition Item as compared to baseline through follow-up terms (Patient's answers range from ''Much Better,'' ''Somewhat Better,'' ''About the Same,'' ''Somewhat Worse,'' to ''Much Worse.'')

    Measured: 2 weeks (or at day of hospital discharge), 3 months, 12 and 12 months postoperatively

  4. Change from baseline in lumbar balance parameters

    To observe the change from baseline in segmental lordosis at operated level by full body X-Ray, in degrees

    Measured: 3 months and 12 months postoperatively

  5. Change from baseline in lumbar balance parameters

    To observe the change from baseline in low lumbar lordosis (L4-S1) by full body X-Ray, in degrees

    Measured: 3 months and 12 months postoperatively

  6. Change from baseline in lumbar balance parameters

    To observe the change from baseline in sagittal vertical axis by full body X-Ray, in degrees

    Measured: 3 months and 12 months postoperatively

  7. Change from baseline in lumbar balance parameters

    To observe the change from baseline in full balance integrated index by full body X-Ray, in degrees

    Measured: 3 months and 12 months postoperatively

  8. Change from baseline in lumbar balance parameters

    To observe the interbody fusion grade by CT , grades by Tan

    Measured: 12 months postoperatively

  9. Adverse Events

    Document Adverse Events (incl. adverse events related to device) occurrence throughout the study

    Measured: during study, an average of 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jul 2025
  2. Study start25 Jun 2025
  3. Primary completion1 Jul 2026
  4. Study completion1 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07050290
Sponsor's protocol ID
NS12-04
Status last verified
Jul 2026
First submitted
25 Jun 2025
Last updated
2 Jul 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Restoring segmental lordosis at the lumbar spine in people with Failed Back Surgery Syndrome and Degeneration Lumbar Spine, run by N.N. Priorov National Medical Research Center of Traumatology and Orthopedics at 1 site in Russia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 2 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline in lumbar balance parameters (time frame: 2 weeks postoperatively (or at day of hospital discharge)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in